$134.83 Million in Sales Expected for Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) This Quarter

Retrieved on: 2021-06-22 05:48:45

Tags for this article:

Click the tags to see associated articles and topics

$134.83 Million in Sales Expected for Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) This Quarter. View article details on hiswai:

Excerpt

Millennium Management LLC now owns 20,532 shares of the specialty pharmaceutical company's stock valued at $538,000 after purchasing an ...

Article found on: www.marketbeat.com